Edition:
United States

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

5.94CNY
20 Sep 2017
Change (% chg)

¥-0.03 (-0.50%)
Prev Close
¥5.97
Open
¥5.97
Day's High
¥5.97
Day's Low
¥5.92
Volume
7,068,909
Avg. Vol
18,709,408
52-wk High
¥9.77
52-wk Low
¥5.24

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 20 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.60 1.60

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-17 1 16,263.00 16,263.00 16,263.00 --
Year Ending Dec-18 1 18,968.00 18,968.00 18,968.00 --
Earnings (per share)
Year Ending Dec-17 1 0.44 0.44 0.44 --
Year Ending Dec-18 1 0.56 0.56 0.56 --

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
Earnings (per share)
Quarter Ending Jun-15 0.02 0.09 0.08 499.35
Quarter Ending Dec-14 0.02 -0.03 0.05 233.33
Quarter Ending Sep-14 -0.06 0.00 0.06 -103.41
Quarter Ending Jun-14 -0.02 0.06 0.08 -366.23
Quarter Ending Dec-13 0.11 -0.04 0.15 135.75

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-17 16,263.00 16,263.00 15,856.00 15,856.00 --
Year Ending Dec-18 18,968.00 18,968.00 18,033.60 18,033.60 --
Earnings (per share)
Year Ending Dec-17 0.44 0.44 0.43 0.43 --
Year Ending Dec-18 0.56 0.56 0.59 0.59 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0